| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate |
2014-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135006c5a9a91a8248d2f5f274536569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33e0633fbe0733c1740f37f6d1e43dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df8224db77117dd6df7065899076edc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77335009f39131e74a8268014b0bdea3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94d5f24f22bfae9840c8b3b8919aec5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1707382e4aa687f151b52f8680fcdf4f |
| publicationDate |
2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180021234-A |
| titleOfInvention |
Compositions and method for treating complement-associated conditions |
| abstract |
The present invention provides methods and compositions for treating a variety of metastatic diseases (e. G., AMD) with a factor D inhibitor (e. G., An anti-factor D antibody or antigen- binding fragment thereof). Also provided is a method of selecting or identifying a patient for treatment with a Factor D inhibitor. Methods include the use of prognostic and / or predictive biomarkers. |
| priorityDate |
2013-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |